======= PRKAR2A =======
== Gene Information ==
* **Official Symbol**: PRKAR2A
* **Official Name**: protein kinase cAMP-dependent type II regulatory subunit alpha
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5576|5576]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P13861|P13861]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PRKAR2A&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRKAR2A|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/176910|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. Type II regulatory chains mediate membrane association by binding to anchoring proteins, including the MAP2 kinase.
|cNMP binding|
|RIIa|
|cAMP-dependent protein kinase regulator activity|
|negative regulation of cAMP-dependent protein kinase activity|
|cAMP-dependent protein kinase inhibitor activity|
|cAMP-dependent protein kinase complex|
|protein kinase A catalytic subunit binding|
|nucleotide-activated protein kinase complex|
|3,5-cyclic-GMP phosphodiesterase activity|
|regulation of cAMP-dependent protein kinase activity|
|activation of protein kinase A activity|
|cAMP binding|
|cGMP-mediated signaling|
|cellular response to glucagon stimulus|
|plasma membrane raft|
|ciliary base|
|renal water homeostasis|
|response to glucagon|
|multicellular organismal water homeostasis|
|water homeostasis|
|axoneme|
|renal system process|
|negative regulation of protein serine/threonine kinase activity|
|cyclic-nucleotide-mediated signaling|
|negative regulation of protein kinase activity|
|protein domain specific binding|
|negative regulation of kinase activity|
|cellular response to peptide hormone stimulus|
|negative regulation of transferase activity|
|blood coagulation|
|ubiquitin protein ligase binding|
|coagulation|
|hemostasis|
|multicellular organismal homeostasis|
|cellular response to peptide|
|activation of protein kinase activity|
|second-messenger-mediated signaling|
|response to peptide hormone|
|negative regulation of protein phosphorylation|
|focal adhesion|
|negative regulation of phosphorylation|
|response to peptide|
|wound healing|
|centrosome|
|regulation of body fluid levels|
|regulation of protein serine/threonine kinase activity|
|positive regulation of protein kinase activity|
|negative regulation of phosphate metabolic process|
|negative regulation of phosphorus metabolic process|
|response to wounding|
|positive regulation of kinase activity|
|negative regulation of protein modification process|
|protein-containing complex|
|cellular response to organonitrogen compound|
|cellular response to hormone stimulus|
|positive regulation of transferase activity|
|cellular response to nitrogen compound|
|negative regulation of catalytic activity|
|regulation of protein kinase activity|
|regulation of kinase activity|
|response to hormone|
|regulation of transferase activity|
|response to organonitrogen compound|
|positive regulation of protein phosphorylation|
|negative regulation of cellular protein metabolic process|
|cellular response to oxygen-containing compound|
|positive regulation of phosphorylation|
|response to nitrogen compound|
|negative regulation of protein metabolic process|
|chemical homeostasis|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|negative regulation of molecular function|
|cellular response to endogenous stimulus|
|positive regulation of protein modification process|
|positive regulation of catalytic activity|
|regulation of protein phosphorylation|
|response to endogenous stimulus|
|response to oxygen-containing compound|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|homeostatic process|
|intracellular signal transduction|
|positive regulation of protein metabolic process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of protein modification process|
|system process|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.81|
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.73|
|[[:results:exp510|Nicotine 3000μM R08 exp510]]|1.92|
|[[:results:exp467|CAY10603 0.55μM R08 exp467]]|2.1|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3281
* **Expression level (log2 read counts)**: 5.54
{{:chemogenomics:nalm6 dist.png?nolink |}}